• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿姆斯特丹痴呆队列研究:实施研究以优化照护。

Amsterdam Dementia Cohort: Performing Research to Optimize Care.

机构信息

Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

J Alzheimers Dis. 2018;62(3):1091-1111. doi: 10.3233/JAD-170850.

DOI:10.3233/JAD-170850
PMID:29562540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5870023/
Abstract

The Alzheimer center of the VU University Medical Center opened in 2000 and was initiated to combine both patient care and research. Together, to date, all patients forming the Amsterdam Dementia Cohort number almost 6,000 individuals. In this cohort profile, we provide an overview of the results produced based on the Amsterdam Dementia Cohort. We describe the main results over the years in each of these research lines: 1) early diagnosis, 2) heterogeneity, and 3) vascular factors. Among the most important research efforts that have also impacted patients' lives and/or the research field, we count the development of novel, easy to use diagnostic measures such as visual rating scales for MRI and the Amsterdam IADL Questionnaire, insight in different subgroups of AD, and findings on incidence and clinical sequelae of microbleeds. Finally, we describe in the outlook how our research endeavors have improved the lives of our patients.

摘要

阿姆斯特丹记忆门诊于 2000 年在阿姆斯特丹 VU 大学医学中心成立,旨在将患者护理和研究结合起来。截至目前,所有组成阿姆斯特丹痴呆队列的患者数量已接近 6000 人。在本队列概况中,我们概述了基于阿姆斯特丹痴呆队列产生的结果。我们描述了这些研究方向中每年的主要结果:1)早期诊断,2)异质性,和 3)血管因素。在对患者生活和/或研究领域产生影响的最重要的研究工作中,我们开发了一些新颖、易于使用的诊断方法,例如 MRI 的视觉评分量表和阿姆斯特丹 IADL 问卷,对 AD 的不同亚组有了更深入的了解,以及关于微出血的发生率和临床后果的发现。最后,我们在展望部分描述了我们的研究工作如何改善了患者的生活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/e25c44d78635/jad-62-jad170850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/93380b2c2dd4/jad-62-jad170850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/3df30e562b15/jad-62-jad170850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/6b349fe94138/jad-62-jad170850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/e25c44d78635/jad-62-jad170850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/93380b2c2dd4/jad-62-jad170850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/3df30e562b15/jad-62-jad170850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/6b349fe94138/jad-62-jad170850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba6/5870023/e25c44d78635/jad-62-jad170850-g004.jpg

相似文献

1
Amsterdam Dementia Cohort: Performing Research to Optimize Care.阿姆斯特丹痴呆队列研究:实施研究以优化照护。
J Alzheimers Dis. 2018;62(3):1091-1111. doi: 10.3233/JAD-170850.
2
Optimizing patient care and research: the Amsterdam Dementia Cohort.优化患者护理与研究:阿姆斯特丹痴呆症队列研究
J Alzheimers Dis. 2014;41(1):313-27. doi: 10.3233/JAD-132306.
3
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.阿尔茨海默病生物标志物日常实践(ABIDE)项目中个体轻度认知障碍患者生物标志物结果的解读
JAMA Neurol. 2017 Dec 1;74(12):1481-1491. doi: 10.1001/jamaneurol.2017.2712.
4
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.用于轻度认知障碍患者阿尔茨海默病所致痴呆早期诊断的结构磁共振成像
Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2.
5
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.结构脑磁共振成像排除阿尔茨海默病痴呆评估中的共病病理学:来自安大略神经退行性疾病研究倡议(ONDRI)研究和过去 10 年临床试验的结果。
J Alzheimers Dis. 2020;74(3):747-757. doi: 10.3233/JAD-191097.
6
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.疑似阿尔茨海默病患者 MRI 定量萎缩测量的临床适用性。
Eur Radiol. 2022 Nov;32(11):7789-7799. doi: 10.1007/s00330-021-08503-7. Epub 2022 May 31.
7
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study.tau-PET 在选定的记忆诊所队列中的影响:TAP-TAU 研究的原理和设计。
Alzheimers Res Ther. 2024 Oct 19;16(1):230. doi: 10.1186/s13195-024-01588-4.
8
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.基于生物标志物的轻度认知障碍患者预后预测(ABIDE):一项建模研究。
Lancet Neurol. 2019 Nov;18(11):1034-1044. doi: 10.1016/S1474-4422(19)30283-2. Epub 2019 Sep 13.
9
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.阿尔茨海默病神经影像学计划2014年更新:自启动以来发表论文综述
Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.
10
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).德国神经退行性疾病研究中心(DZNE)关于前驱期阿尔茨海默病的多中心观察性研究(DELCODE)的设计和初步基线数据。
Alzheimers Res Ther. 2018 Feb 7;10(1):15. doi: 10.1186/s13195-017-0314-2.

引用本文的文献

1
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia.大规模脑脊液蛋白质组分析鉴定出用于额颞叶痴呆准确诊断的生物标志物。
Mol Neurodegener. 2025 Aug 27;20(1):93. doi: 10.1186/s13024-025-00882-5.
2
Subjective memory complaints of patients and caregivers and their association with sociodemographic and clinical factors in patients with neurocognitive disorders from Colombia.哥伦比亚神经认知障碍患者及其照料者的主观记忆主诉及其与社会人口学和临床因素的关联
Res Sq. 2025 Jul 14:rs.3.rs-7040277. doi: 10.21203/rs.3.rs-7040277/v1.
3
Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology.

本文引用的文献

1
Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project.患者及照护者对阿尔茨海默病诊断检测中对话及共同决策的看法:ABIDE项目
Alzheimers Dement (N Y). 2017 May 10;3(3):314-322. doi: 10.1016/j.trci.2017.04.002. eCollection 2017 Sep.
2
Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project.临床医生对阿尔茨海默病诊断测试中对话及共同决策的看法:ABIDE项目
Alzheimers Dement (N Y). 2017 May 10;3(3):305-313. doi: 10.1016/j.trci.2017.03.009. eCollection 2017 Sep.
3
用于检测淀粉样蛋白病理学的临床应用中血浆磷酸化 Tau 217 的高精度全自动数字免疫测定法的分析和临床验证。
Front Neurol. 2025 Jul 9;16:1568971. doi: 10.3389/fneur.2025.1568971. eCollection 2025.
4
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients.几丁质酶1(CHIT1)和二甲基精氨酸二甲胺水解酶1(DDAH1)水平与阿尔茨海默病患者淀粉样蛋白相关成像异常风险概况相关。
Alzheimers Res Ther. 2025 Jul 22;17(1):169. doi: 10.1186/s13195-025-01799-3.
5
Subcortical gray matter volumes and 5-year dementia risk in individuals with subjective cognitive decline or mild cognitive impairment: A multi-cohort analysis.主观认知下降或轻度认知障碍个体的皮质下灰质体积与5年痴呆风险:一项多队列分析
Alzheimers Dement. 2025 Jul;21(7):e70413. doi: 10.1002/alz.70413.
6
Increased genetic protection against Alzheimer's disease in centenarians.百岁老人对阿尔茨海默病的遗传保护增强。
Geroscience. 2025 Jul 4. doi: 10.1007/s11357-025-01774-8.
7
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.血浆Aβ42/40比值、磷酸化tau181、胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)在阿尔茨海默病和非阿尔茨海默病性痴呆连续病程中的诊断性能:一项国际多中心研究
Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.
8
"Real-world" eligibility for anti-amyloid treatment in a tertiary memory clinic setting.三级记忆诊所环境中抗淀粉样蛋白治疗的“真实世界”适用性。
Alzheimers Dement. 2025 Jun;21(6):e70375. doi: 10.1002/alz.70375.
9
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [F]flortaucipir imaging: TAU-SPEX.作为[F]氟替卡匹尔成像视觉解读潜在辅助手段的PET空间范围定量分析:TAU-SPEX。
Eur J Nucl Med Mol Imaging. 2025 Jun 7. doi: 10.1007/s00259-025-07384-y.
10
Plasma and MRI biomarkers capture neuronal damage in former professional boxers.血浆和核磁共振成像生物标志物可捕捉前职业拳击手的神经元损伤情况。
Sci Rep. 2025 Jun 6;15(1):20005. doi: 10.1038/s41598-025-93066-6.
Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making.
阿尔茨海默病的诊断困境:共同决策的空间
Alzheimers Dement (N Y). 2017 May 9;3(3):301-304. doi: 10.1016/j.trci.2017.03.008. eCollection 2017 Sep.
4
Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment.ExCersion-VCI研究设计:有氧运动对血管性认知障碍患者脑灌注的影响。
Alzheimers Dement (N Y). 2017 Mar 6;3(2):157-165. doi: 10.1016/j.trci.2017.02.002. eCollection 2017 Jun.
5
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.阿尔茨海默病生物标志物日常实践(ABIDE)项目中个体轻度认知障碍患者生物标志物结果的解读
JAMA Neurol. 2017 Dec 1;74(12):1481-1491. doi: 10.1001/jamaneurol.2017.2712.
6
Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease.阿尔茨海默病前驱期患者的灰质网络与临床进展。
Neurobiol Aging. 2018 Jan;61:75-81. doi: 10.1016/j.neurobiolaging.2017.09.011. Epub 2017 Sep 20.
7
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.基于生物标志物的阿尔茨海默病早期诊断的战略路线图。
Lancet Neurol. 2017 Aug;16(8):661-676. doi: 10.1016/S1474-4422(17)30159-X. Epub 2017 Jul 11.
8
Directional information flow in patients with Alzheimer's disease. A source-space resting-state MEG study.阿尔茨海默病患者的定向信息流。一项源空间静息态脑磁图研究。
Neuroimage Clin. 2017 Jun 17;15:673-681. doi: 10.1016/j.nicl.2017.06.025. eCollection 2017.
9
EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects.脑电图频谱分析作为非痴呆、淀粉样蛋白阳性受试者的一种假定早期预后生物标志物。
Neurobiol Aging. 2017 Sep;57:133-142. doi: 10.1016/j.neurobiolaging.2017.05.017. Epub 2017 Jun 1.
10
Consensus guidelines for lumbar puncture in patients with neurological diseases.神经疾病患者腰椎穿刺的共识指南。
Alzheimers Dement (Amst). 2017 May 18;8:111-126. doi: 10.1016/j.dadm.2017.04.007. eCollection 2017.